Tiankang Biotech: Announcement on the progress of capital increase to wholly-owned subsidiaries through debt-for-equity swaps
Tiankang Biology: Legal Opinion on the 5th Extraordinary General Meeting of Shareholders of Tiankang Biotech Co., Ltd. in 2024
Tiankang Biotech: Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2024
Tiankang Biotech: Notice on Convening the Fifth Extraordinary General Meeting of Shareholders in 2024
Tiankang Biotech: Announcement on capital increase to wholly-owned subsidiaries through debt-for-equity swaps
Tiankang Biotech: Semi-annual non-operating capital usage and other related capital transactions summary table
Tiankang Biology: 2024 Semi-Annual Financial Report
Tecon Biology Co.Ltd: Legal Opinion on the Fourth Extraordinary Shareholders' Meeting of Tecon Biology Co., Ltd. in 2024.
Tecon Biology Co.Ltd: Announcement of Resolutions of the Fourth Extraordinary Shareholders' Meeting in 2024.
Tecon Biology Co.Ltd: Notice of the Fourth Extraordinary Shareholders' Meeting to be held in 2024.
Tecon Biology Co.Ltd: Notice on completing the registration of the change of legal representative and the issuance of a business license
Tecon Biology Co.Ltd: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Tecon Biology Co.Ltd: Legal Opinion on the 2023 Annual General Meeting of Shareholders of Tiankang Biotech Co., Ltd.
Tecon Biology Co.Ltd: Notice on subsidiaries' use of idle own funds for cash management
Tecon Biology Co.Ltd: Notice of Annual General Meeting of Shareholders
Tecon Biology Co.Ltd: Announcement on preparation for the 2023 inventory price drop
Tecon Biology Co.Ltd: Goodwill impairment test report
Tecon Biology Co.Ltd: Internal Control Self-Assessment Report
Tecon Biology Co.Ltd: Self-inspection form for the implementation of internal control rules
Tecon Biology Co.Ltd: 2023 Annual Financial Report
No Data
No Data